7月15日电，亚盛医药在港交所公告，拟通过先旧后新配售不超过2200万股股票，配售价为每股68.6港元，筹集约15.1亿港元。

Group 1 - The company, Ascentage Pharma, announced a plan to issue up to 22 million shares through a placement, with a price of HKD 68.6 per share, aiming to raise approximately HKD 1.51 billion [1]